Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
Drug resistant tuberculosis is increasing world-wide. Resistance against isoniazid (INH), rifampicin (RIF), or both (multi-drug resistant TB, MDR-TB) is of particular concern, since INH and RIF form part of the standard regimen for TB disease. While it is known that suboptimal treatment can lead to...
Main Authors: | Elsje Pienaar, Jennifer J Linderman, Denise E Kirschner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5944939?pdf=render |
Similar Items
-
Deletion of TGF-β1 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model
by: Hayley C. Warsinske, et al.
Published: (2017-12-01) -
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01) -
Rapid Detection for Early Appearance of Rifampin and Isoniazid Resistance in Mycobacterium Tuberculosis
by: Dhanida Rienthong, et al.
Published: (2009-01-01) -
Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach.
by: Elsje Pienaar, et al.
Published: (2017-08-01) -
Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
by: Valéria G. F. Pinheiro, et al.